Divestitures “skyrocketed” in 2024, with asset sales accounting for 45 of 72 announced deals, according to the consultancy.

Healthcare fraud investigations accounted for more than half of the Department of Justice's settlements and judgments in 2024 ...

After a turbulent year, things should calm for payers with the advent of a business-friendly Trump administration — though ...

The shape of AI regulation will be uncertain under the Trump administration this year, while healthcare companies will ...

UnitedHealth’s net income plummeted to its lowest level since 2019 amid hefty costs, including some from the Change ...

Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...

Announcing the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final health ...

Investors focused their dollars on younger startups, while deal sizes for more established companies declined last year.

Entering the marketplace could help drive enrollment in Teladoc’s chronic care management programs, executives with the ...

A rule finalized Monday makes it easier for regulators to suspend agents and brokers from selling Affordable Care Act plans ...

The agency’s road map, which outlines goals for promoting safe and equitable adoption, comes as the future of AI policy is ...

Antitrust regulators have reached a deal with Welsh, Carson, Anderson and Stowe that doesn’t penalize the private equity firm ...